- Home
- LUCY vs BMRA Comparison
LUCY vs BMRA Comparison
Compare LUCY & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCY
- BMRA
- Stock Information
- Founded
- LUCY 2017
- BMRA 1971
- Country
- LUCY United States
- BMRA United States
- Employees
- LUCY N/A
- BMRA N/A
- Industry
- LUCY Ophthalmic Goods
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LUCY Health Care
- BMRA Health Care
- Exchange
- LUCY Nasdaq
- BMRA Nasdaq
- Market Cap
- LUCY 18.5M
- BMRA 7.4M
- IPO Year
- LUCY 2022
- BMRA N/A
- Fundamental
- Price
- LUCY $6.90
- BMRA $0.32
- Analyst Decision
- LUCY Strong Buy
- BMRA
- Analyst Count
- LUCY 1
- BMRA 0
- Target Price
- LUCY $20.00
- BMRA N/A
- AVG Volume (30 Days)
- LUCY 104.1K
- BMRA 68.2K
- Earning Date
- LUCY 11-12-2024
- BMRA 10-15-2024
- Dividend Yield
- LUCY N/A
- BMRA N/A
- EPS Growth
- LUCY N/A
- BMRA N/A
- EPS
- LUCY N/A
- BMRA N/A
- Revenue
- LUCY $1,529,782.00
- BMRA $5,509,000.00
- Revenue This Year
- LUCY $245.17
- BMRA N/A
- Revenue Next Year
- LUCY $258.97
- BMRA N/A
- P/E Ratio
- LUCY N/A
- BMRA N/A
- Revenue Growth
- LUCY 186.54
- BMRA 1.74
- 52 Week Low
- LUCY $3.26
- BMRA $0.24
- 52 Week High
- LUCY $27.20
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- LUCY 44.95
- BMRA 47.45
- Support Level
- LUCY $6.33
- BMRA $0.28
- Resistance Level
- LUCY $6.89
- BMRA $0.35
- Average True Range (ATR)
- LUCY 0.59
- BMRA 0.03
- MACD
- LUCY -0.27
- BMRA 0.00
- Stochastic Oscillator
- LUCY 14.46
- BMRA 38.50
About LUCY Innovative Eyewear Inc.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products Lucyd Lyte glasses enable the wearer to listen to music, take and make calls, and use voice assistants to perform many common smartphone tasks hands free.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.